About this trial
This study tests a new non-invasive device called DARE to monitor blood pressure in patients in intensive care. It compares the device's readings to standard invasive methods and also looks at how well it measures other vital signs like temperature, oxygen levels, and heart rhythm. The goal is to improve patient safety and comfort while helping doctors detect problems earlier.
Eligibility criteria
Qualifiers
Adult patients (male or female), aged 18 years or older
Admitted to intensive care unit (ICU) or critical care with an expected hospital stay longer than 2 days
Equipped with an arterial catheter for invasive blood pressure monitoring
Equipped with a urinary catheter for invasive core body temperature monitoring
Disqualifiers
Patients under 18 years old (minors)
Known skin allergy to adhesives or silicone, or skin condition preventing adhesive use
History of extensive skin pathology (e.g., Lyell syndrome)
Patients with therapeutic limitations
Trial design
Treatments tested in this trial
- MultiSense® Non-Invasive Hemodynamic Monitoring Device